He is also the the NIHR Oxford Biomedical Research Centre’s Musculoskeletal Co-theme Lead. Duncan is working with a diverse range of Oxford biomedical researchers and more widely with the pharmaceutical, biotechnology and diagnostics industries, in order to drive new drug treatments through decision-making in early phase clinical trials.
